Prediction of therapy-related acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) after autologous bone marrow transplant (ABMT) for lymphoma

American Journal of Hematology

Volumn 56, Issue 1, 1997, Pages 45-51

  Legare, Robert D ^a   Gribben, John G ^b   Maragh, Marlon ^a   Hermanowski Vosatka, Anne ^a   Roach, Sheila ^b   Tantravahi, Ramana ^b   Nadler, Lee M ^b   Gilliland, D Gary ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Autologous bone marrow transplant; Chemotherapy; Clonality; Leukemia; lymphoma; Myelodysplasia; Secondary malignancy

Indexed keywords

ANDROGEN RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CASE REPORT; CELL GROWTH; HEMATOPOIESIS; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK FACTOR; SECOND CANCER; X CHROMOSOME;

ALLELES; BONE MARROW TRANSPLANTATION; FEMALE; HEMATOPOIESIS; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; LYMPHOMA; MYELODYSPLASTIC SYNDROMES; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; RECEPTORS, ANDROGEN; TRANSPLANTATION, AUTOLOGOUS; X CHROMOSOME;

EID: 0030967770     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199709)56:1<45::AID-AJH10>3.0.CO;2-1     Document Type: Article

References (21)

1. Jagannath S, et al.: Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease. J Clin Oncol 7:179, 1989.
2. Stone R: Myelodysplastic syndrome after autologous transplantation for lymphoma: The price of progress? Blood 83:3437, 1994.
3. Stone R, et al.: Myelodysplastic syndrome as a late complication following autologous bone marrow transplant for non-Hodgkin's lymphoma. J Clin Oncol 12:2535, 1994.
4. Traweek S, et al.: Clonal karyoptypic hematopoietic cell abnormalities occurring after autologous bone marrow transplant for Hodgkin's disease and non-Hodgkin's lymphoma. Blood 84:957, 1994.
5. Miller J, et al.: Myelodysplastic syndrome after autologous bone marrow transplantation: An additional late complication of curative cancer therapy. Blood 83:3780, 1994.
6. Busque L, Gilliland DG: Clonal evolution in acute myeloid leukemia. Blood 82:337, 1993.
7. Allen R, Zoghbi H, Moseley A, Rosenblatt H, Belmont J: Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 51:1229, 1992.
8. Willman C, et al.: Langerhans'-cell histiocytosis (Histiocytosis X): A clonal proliferative disease. N Engl J Med 331:154, 1994.
9. Busque L, et al.: Clonality of bone marrow repopulation after allogeneic and autologous bone marrow transplantation (ABMT). Blood 82(Suppl 1): 1813, 1993 (abstr).
10. Busque L, et al.: An expression based clonality assay at the human androgen receptor locus (HUMARA) on chromosome X. Nucleic Acids Res 22:697, 1994.
11. Busque L, et al.: Clonality in juvenile chronic myelogenous leukemia. Blood 85:21, 1994.
12. Gale R, Wheadon H, Goldstone A, Burnett A, Linch D: Frequency of clonal remission in acute myeloid leukaemia. Lancet 341:138, 1993.
13. Freedman A, et al.: Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma. Blood 77:2524, 1991.
14. Rosenbloom B, Schreck R, Koeffler H: Therapy-related myelodysplastic syndromes. Hematol Oncol Clin North Am 6:707, 1992.
15. Shipp M, et al.: A predictive model for aggressive NHL. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 329:987, 1993.
16. Legare R, Gilliland D: Myelodysplastic syndrome. Curr Opin Hematol 2:283, 1995.
17. Asano G, et al.: Evidence for nonclonal hematopoietic progenitor cell populations in bone marrow of patients with myelodysplastic syndromes. Blood 84:588, 1994.
18. Rowley JD: Chromosomal translocations in secondary acute myeloid leukaemia. N Engl J Med 334:601, 1996.
19. Lyons M: Gene action in the X-chromosome of the mouse (Mus Musculus L). Nature 190:372, 1961.
20. Gale R, Wheadon H, Boulos P, Linch D: Tissue specificity of X-chromosome inactivation patterns. Blood 83:2899, 1994.
21. Gale R, et al.: Demonstration of developing myelodysplasia/acute myeloid leukemia in haematologically normal patients after high-dose chemotherapy and autologous bone marrow transplantation using X-chromosome inactivation patterns. Br J Haematol 93:53, 1996.